New Mexico Tech Monitor
SEE OTHER BRANDS

Exploring the science and technology news of New Mexico

New Mexico Tech Monitor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Tech Monitor.

Press releases published on May 1, 2025

SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results

SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results

NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on …

Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

Study ANAVEX3-71-SZ-001 successfully completes enrollment with a total of 71 participants Both Part A (16 participants) and Part B (55 participants) of the placebo-controlled Phase 2 study fully enrolled Top line data expected in the second half of 2025 …

Altimmune to Present at Upcoming EASL International Liver Congress™ 2025

Altimmune to Present at Upcoming EASL International Liver Congress™ 2025

GAITHERSBURG, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced that the …

Prelude Therapeutics to Participate in Citizens Life Sciences Conference

Prelude Therapeutics to Participate in Citizens Life Sciences Conference

WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens Life Sciences Conference taking …

Digi Power X Maintains Strong Cash and Crypto Position with Debt-Free Operations and Reports April 2025 Production Results

Digi Power X Maintains Strong Cash and Crypto Position with Debt-Free Operations and Reports April 2025 Production Results

MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), a vertically integrated power infrastructure company focused on developing cutting-edge data centers for high-performance computing, is …

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

As SVP, Neuroscience, Dr. Bordey will lead Cassava’s ongoing research and development efforts Dr. Bordey to direct the scientific evaluation of simufilam in TSC-related epilepsy, and potentially additional pipeline indications AUSTIN, Texas, May 01, 2025 ( …

WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with SpaceX Featuring Encrypted Communications and SEALCOIN Integration

WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with SpaceX Featuring Encrypted Communications and SEALCOIN Integration

WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with SpaceX Featuring Encrypted Communications and SEALCOIN Integration Geneva, Switzerland, May 1, 2025 –WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading …

Draganfly and Autonome Labs Announce Teaming Agreement to Deliver UAV-Based Demining Mesh Deployment Solution

Draganfly and Autonome Labs Announce Teaming Agreement to Deliver UAV-Based Demining Mesh Deployment Solution

Tampa, FL, May 01, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) ("Draganfly" or the "Company") an industry-leading developer of drone solutions and systems is pleased to announce a strategic teaming agreement with Autonome …

Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference

Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference

ALPHARETTA, Ga., May 01, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that …

Crane NXT Completes Acquisition of De La Rue Authentication Solutions

Crane NXT Completes Acquisition of De La Rue Authentication Solutions

WALTHAM, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT) ("Crane NXT" or the "Company"), a premier industrial technology company, today announced it has completed its acquisition of De La Rue Authentication Solutions, a global leader in …

Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

VOQUEZNA launch momentum continues with over 390,000 prescriptions filled to date, written by more than 23,600 healthcare providers Net revenues of $28.5 million reported for Q1 Filled VOQUEZNA prescriptions increased ~8% in Q1 over the prior quarter …

Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update

Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update

– Reported positive topline results from the Phase 3 VERITAC-2 trial that support global regulatory filings – – Presented first-in-human data for the Company’s first neuroscience program with ARV-102 showing blood-brain barrier penetration and central and …

Eccogene Appoints Dr. Jai Patel as Chief Medical Officer

Eccogene Appoints Dr. Jai Patel as Chief Medical Officer

BOSTON and SHANGHAI, May 01, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammatory conditions, today announced the appointment …

BioCryst Appoints Steve Frank to Board of Directors

BioCryst Appoints Steve Frank to Board of Directors

RESEARCH TRIANGLE PARK, N.C., May 01, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed healthcare investment banking leader Steve Frank to its board of directors. Mr. Frank serves as …

Fortrea Named a Leader in Everest Group’s Pharmacovigilance Operations PEAK Matrix® Assessment 2025

Fortrea Named a Leader in Everest Group’s Pharmacovigilance Operations PEAK Matrix® Assessment 2025

DURHAM, N.C., May 01, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced it has been recognized as a “Leader” for pharmacovigilance (PV) operations by Everest Group in its annual …

Climb Channel Solutions Launches Global Partnership with Accelsius LLC

Climb Channel Solutions Launches Global Partnership with Accelsius LLC

EATONTOWN, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB), is excited to announce its new partnership with …

Lantronix to Report Fiscal 2025 Third Quarter Results on May 8, 2025

Lantronix to Report Fiscal 2025 Third Quarter Results on May 8, 2025

IRVINE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (the “Company”) (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling AI Edge Intelligence, today announced it will release financial results from its fiscal …

Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report first quarter 2025 financial results on May 12, 2025, before the open of the U.S. financial markets. The company does not intend to hold a …

Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates

Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates

First-quarter 2025 Rezdiffra™ (resmetirom) net sales of $137.3 million As of March 31, 2025, more than 17,000 patients on Rezdiffra Two-year compensated MASH cirrhosis (F4c) data from MAESTRO-NAFLD-1 trial selected as oral late-breaker at EASL Congress ( …

FactSet Increases Dividend

FactSet Increases Dividend

NORWALK, Conn., May 01, 2025 (GLOBE NEWSWIRE) -- FactSet (NYSE: FDS | NASDAQ: FDS), a global financial digital platform and enterprise solutions provider, today announced that its Board of Directors approved a 6% increase in the regular quarterly cash …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service